Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 1Locally Recurrent Skin Squamous Cell Carcinoma 1Carcinoma, Adenoid Cystic 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Epirubicin 2pembrolizumab 1lenvatinib 1anlotinib 1amivantamab 1Pemetrexed 1Observation 1Nivolumab 1Ipilimumab 1Glutamate Carboxypeptidase II 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Adenoid Cystic × amivantamab × 30 days × Clear all
NCT05074940 2026-05-08

Amivantamab in Adenoid Cystic Carcinoma

University of Cincinnati

Phase 2 Active not recruiting
21 enrolled 13 charts
Head & Neck

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡